VISENSIA

by OBS MEDICAL  · Based in United Kingdom →Life Saving Insight for Proactive Healthcare
Critical Care Emergency Medicine Hospital Medicine

A 1-bed perpetuity license costs £1950. individual hospital systems are priced according to size and include installation and configuration charges. other purchasing models, such as bed license purchase and leasing via annual or monthly payments, are available.
Regulatory Status Disclosed

Overview

Visensia, developed by OBS Medical, is an advanced physiological monitoring software that leverages artificial intelligence to analyze continuous or episodic vital sign data. It fuses up to five vital signs—heart rate, respiration rate, temperature, oxygen saturation, and blood pressure—into a single, intuitive metric called the Visensia Safety Index (VSI). This index provides healthcare professionals with an early warning of patient deterioration, often hours before traditional methods, thereby enhancing patient safety and enabling timely clinical intervention. Designed as an accessory to standard multi-parameter patient monitors or clinical information systems, Visensia integrates seamlessly with existing hospital infrastructure via a standard Health Level 7 (HL7) interface. The system offers various display options, including a ‘Bingo Board’ for an overview of multiple patients and a ‘Drill Down’ for detailed patient information, along with automated audible and visual alerts when the VSI exceeds defined thresholds. Visensia is utilized across various care settings, including hospitals (general wards, critical care), emergency medical services (EMS), and remote patient monitoring in community and home environments.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Fuses 5 vital signs (Heart Rate, Respiration Rate, Temperature, Oxygen Saturation, Blood Pressure) into a single Visensia Safety Index (VSI).
  • Early detection of patient deterioration (average 6 hours, up to 24 hours in some settings).
  • Automated audible and visual alerts for critical instability.
  • Simplification of complex vital sign data for clinicians.
  • Risk identification and prevention of clinical crisis.
  • Prioritizes clinical workflow and resource utilization.
  • Enhances situational awareness across the care continuum.
  • Integrates with existing patient monitoring infrastructure via HL7 interface.
  • Mobile application for VSI alert notifications and patient review.
  • Objective patient assessment for step-down or discharge decisions.

Use Cases

  • Hospital patient monitoring (general wards, critical care).
  • Remote patient monitoring and home healthcare.
  • Emergency Medical Services (EMS) for patient assessment.
  • Clinical decision support for patient risk stratification.
  • Optimizing patient admission, transfer, and discharge processes.
  • Reducing unexpected deaths and 'code blue' events.

What Physicians Need to Know

Evidence Base
Visensia utilizes an AI-based algorithm that compares a patient's five vital signs (Heart Rate, Respiration Rate, Blood Oxygen Saturation, Temperature, and Blood Pressure) against a unique, data-driven model of normality derived from real-world, high-risk patient datasets. The system has received both CE mark and FDA approval.
Clinical Validation Studies
Extensive clinical trials in the UK and USA have validated Visensia's efficacy. A 3-phase study at the University of Pittsburgh Medical Centre (UPMC) demonstrated a mean advanced detection time of 6.33 hours prior to Medical Emergency Team (MET) activation. Phase 3 of this study showed a 58% reduction in critical instability episodes and no unexpected deaths in the monitored unit. Data from St. Joseph Mercy Oakland Hospital over four years reported a 37.5% decline in code-blue responses, a 34.5% reduction in mortality rates, and a reduction in patient length of stay. Proof of concept work confirmed 95% of identified severe physiological abnormalities were valid alerts.
Alert Fatigue Management
Visensia addresses alarm fatigue by providing validated and appropriate alerts with high sensitivity and specificity, significantly reducing clinically insignificant alarms compared to single-channel systems. The system generates a simple, unambiguous audible and visual alert when the Visensia Index (VSI) exceeds a predefined, clinically validated threshold (VSI > 3), which cannot be altered by users.
Override Rate Data
Specific override rate data for clinician actions is not explicitly provided. However, the system is designed to automatically override manually entered vital signs with new data received from configured patient monitoring systems.
Drug Interaction Checking
Information regarding drug interaction checking is not a stated feature of Visensia based on the available documentation. The tool focuses on physiological vital sign analysis for patient deterioration.
Differential Diagnosis Support
Visensia provides a single numerical index (VSI) indicating patient wellness or risk of deterioration. It also displays the contribution of each vital sign to the index, which can help clinicians identify the underlying physiological causes of abnormality and guide further assessment. It assists in assessing patient stabilization or improvement for discharge planning.
Guideline Update Frequency
The frequency of updates to Visensia's underlying algorithms or database is not explicitly detailed. The Visensia Index (VSI) is continuously recalculated whenever new vital sign data is received.
Clinical Workflow Integration
Visensia offers a standard Health Level 7 (HL7) interface for seamless communication with existing data acquisition systems, including multi-parameter patient monitors, Electronic Medical Records (EMR), and Clinical Information Systems (CIS). It functions as an accessory to standard monitoring systems and can process both continuous and episodic vital sign data. The client display is a web application that can be customized for various hospital layouts, aiding in prioritizing clinical workflow and resource utilization.
Physician Tip

Visensia is a powerful tool for early detection of patient deterioration, offering a clear, validated 'Safety Index' (VSI) that fuses multiple vital signs into a single, actionable score. Physicians should leverage the VSI for proactive intervention, prioritizing patients at highest risk, and to objectively assess patient stability for care escalation or de-escalation. Its high sensitivity and specificity help to reduce alarm fatigue, allowing for more focused clinical attention. Integrate Visensia into your existing patient monitoring protocols to enhance situational awareness and improve communication among care teams.

Visensia is designed for flexible integration within diverse healthcare IT environments. Its use of a standard HL7 interface ensures compatibility with a wide range of existing patient monitoring systems, EMRs, and CIS. This allows healthcare organizations to utilize their current infrastructure, facilitating a smooth deployment and enabling real-time data flow for continuous and episodic vital sign analysis.

Details

Category Clinical Decision Support & Reference, Triage & ER/ICU AI, Wearables & Remote Monitoring (RPM)
Pricing A 1-bed perpetuity license costs £1950. individual hospital systems are priced according to size and include installation and configuration charges. other purchasing models, such as bed license purchase and leasing via annual or monthly payments, are available.
  • £1950 for a 1-bed perpetuity license; individual hospital systems priced by size, including installation and configuration; annual or monthly leasing options
DeploymentClient-server computer program, with the client running as a web application in a web browser.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Visensia with Alert received FDA 510(k) clearance (K081140 on 07/17/2008 and K110953 on 05/16/2011) as an accessory to multi-parameter patient monitors or clinical information systems, indicated for use by healthcare professionals with non-pediatric high dependency care patients.

Integrations
EHR Not specified
Specialties Critical Care, Emergency Medicine, Hospital Medicine

What the Web Says

Visensia is physiological monitoring software that analyzes data from bedside monitors on five vital signs (heart rate, blood pressure, temperature, oxygen saturations, and respiration rate) to produce a single patient health status score, called the Visensia Safety Index (VSI). This score is used for the early identification of patient deterioration that might lead to cardiac or respiratory arrest. Studies have shown that Visensia can provide several hours of advanced warning of critical instability and has been associated with a reduction in code-blue responses, mortality rates, and length of patient stay in some hospital settings. It is the first FDA-cleared and CE-marked index for multiple physiological parameter assessment with automated alerts.

Overall: Positive

Strengths

  • Early detection of patient deterioration, providing several hours of advanced warning.
  • Reduction in code-blue responses and mortality rates in some implementations.
  • Shorter average duration of cardio-respiratory instability.
  • Automated calculation of a single, unambiguous safety index (VSI) for easy assessment and communication.
  • Integrates with standard bedside monitors.
  • FDA cleared and CE marked.

Limitations

  • Technical problems with the software prevented recording for the whole monitoring period in some patients during studies.
  • Study results may have been confounded by changes in ward care and additional training for nurses and physicians.
  • Limited usefulness for level 2 patients who may have invasive monitoring.
  • Accuracy of predicting the use of tracheal intubation and non-invasive positive pressure ventilation (NPPV) was low in one study.
  • Retrospective study at a single facility, requiring prospective multi-center studies for verification.

Based on reviews from: NICE, OBS Medical, Research - Patient.info

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate VISENSIA

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

OBS Medical
OBS Medical receives Health Canada Authorisation for Visensia
OBS Medical announced that Health Canada has authorized Visensia for early recognition and response to clinical deterioration in hospital patients, aiming to reduce unexpected deaths through continuous vital sign monitoring and an Early Warning System.
2024-04
Critical Care Medicine
724: AI-BASED VISENSIA INDEX VS SMEWS FOR MORTALITY PREDICTION IN 13 HIGH-PERFORMING JAPANESE HOSPITALS
A study in 13 Japanese hospitals compared the AI-based Visensia Safety Index (VSI) with the Marianna Modified Early Warning Score (SMEWS) for predicting ward deaths, finding VSI to have higher sensitivity and better model performance.
2026-03
PubMed (Journal of Medical Systems)
Comparing Continuous with Periodic Vital Sign Scoring for Clinical Deterioration Using a Patient Data Model
This prospective comparative study evaluated the Visensia Safety Index (VSI) against periodic Early Warning Scores (EWS) for detecting clinical deterioration, finding that continuous VSI monitoring provided earlier alerts but with a higher number of warnings.
2023-05
OBS Medical
OBS Medical celebrates the announcement of Excel Medical's successful FDA clearance for their next generation clinical decision support platform - WAVE featuring Visensia
OBS Medical announced that Excel Medical received FDA clearance for its WAVE Clinical Platform, which integrates Visensia for advanced prediction and prevention of patient deterioration.
2018-01
Prescient Healthcare
New joint venture
Prescient Healthcare and OBS Medical formed a joint venture, ViSIG Health, LLC, to combine their technologies (rSIGNIPHY and Visensia) into a novel early warning system for intensive care units.
2020-01
National Institute for Health and Care Excellence (NICE)
Visensia for early detection of deteriorating vital signs in adults in hospital | NICE
NICE published a briefing on Visensia physiological monitoring software, detailing its use by healthcare professionals for routine monitoring of high-risk adult patients to provide early warning of deterioration.
2015-08
FDA
510(k) Premarket Notification
The FDA reviewed OBS Medical's 510(k) premarket notification for Visensia, determining it substantially equivalent to predicate devices for patient physiological monitoring with arrhythmia detection or alarms.
2011-05
ClinicalTrials.gov
Predictive Monitoring for Clinical Deterioration (VSI Trial)
This unphased trial is testing the Visensia Safety Index (VSI) as a new monitoring system to detect early signs of health problems in hospital patients, aiming to enable prompt action and potentially improve patient outcomes.
unknown

Videos

Product demos, reviews, and walkthroughs for VISENSIA.

View all on YouTube

No FAQs available yet for this tool.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18

Investors who backed VISENSIA

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.